Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7049887 | 0.84 | P2RX3 (0.50) | — | |
| SCHEMBL7050913 | 0.83 | THRA (0.43) | THRATHRB | |
| SCHEMBL7050188 | 0.82 | THRA (0.52) | THRATHRB | |
| SCHEMBL7053398 | 0.80 | THRA (0.47) | THRATHRB | |
| SCHEMBL7054876 | 0.74 | NR3C1 (0.51) | THRATHRB | |
| SCHEMBL16736859 | 0.74 | ALOX15 (0.48) | THRATHRB | |
| SCHEMBL2044734 | 0.71 | THRA (0.71) | THRATHRB | |
| SCHEMBL7050517 | 0.70 | THRA (0.49) | THRATHRB | |
| SCHEMBL11665052 | 0.69 | ALOX15 (0.50) | THRB | |
| SCHEMBL7055363 | 0.68 | NR3C1 (0.50) | THRATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1102739-B1 | GLUCOCORTICOID AND THYROID HORMONE RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS | KAROBIO AB (SE) | 2003-04-23 | — | — | EP | disclosed |
| US-6492424-B1 | Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders | KARO BIO AB (SE) | 2002-12-10 | — | — | US | disclosed |
| EP-1102739-A1 | GLUCOCORTICOID AND THYROID HORMONE RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS | KARO BIO AB (SE) | 2001-05-30 | — | — | EP | disclosed |
| WO-2000007972-A1 | GLUCOCORTICOID AND THYROID HORMONE RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS | KARO BIO AB (SE) | 2000-02-17 | — | — | WO | disclosed |